日本将颁发新的抗肿瘤药准则在日本，新的评价临床抗肿瘤药物的准则已经起草，并且有望很快定稿，其焦点在于后期实验的实施上。实验的主要目的是要更明确药物的安全性与有效性，以及改进实验的观察方法。在此方针下，为了促进其可用性（有效性），某些药物（假设目前有满... Japan to Issue New Guidelines for Antineoplastic Agents In Japan, new guidelines for evaluating clinical antineoplastic drugs have been drafted and are expected to be finalized soon, with a focus on the implementation of later experiments. The main purpose of the experiment is to more clearly the safety and effectiveness of the drug, as well as to improve the experimental observation method. Under this policy, in order to promote its availability (effectiveness), certain drugs (assuming there are currently full ...